Navion Neurosciences
Navion Neurosciences is a pre-clinical stage biotechnology company that develops sodium channel therapeutics for neurological diseases.
$10.8M Seed ·
Led by Angelini Lumira Biosciences Fund · Source: biospace.com
Funding history ↓Signals
Website registeredJun 24, 2025 (17 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $10.8M | biospace.com |
Timeline
- Website created
Founders and team
AJ
Andrew J. Krouse FounderMP
Manoj Patel FounderMH
Michelle Higgin FounderTR
Tom Richardson FounderMI
Michael Innes CBO
Investors
33B Future Health Fund
AAngelini Lumira Biosciences Fundlead investor- KKids Connect Charitable Fund
UUVA Licensing & Ventures GroupVVirginia Innovation Partnership Corporation
VVirginia Tech Carilion (VTC) Innovation Fund
Companies like Navion Neurosciences
LLUCA Science$30M Series B+ · Jun 2022BBloom Science$12M Series A · Dec 2021
VVaderis Therapeutics$152M Series B+ · Aug 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
AAtavistik Bio$40M Series B+ · Mar 2026
CCity TherapeuticsSeries B+ · Aug 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/navion-neurosciences (get a free API key).